1 Welcome
Protein aggregation is behind the onset of an increasing number of human diseases and constitutes one of the major bottlenecks for marketing protein-based therapeutics.
The main goal of this training school is to provide expertise on fundamental aspects of protein aggregation. The course will cover the impact of this phenomenon on age-related diseases, how it can be targeted, and its implications for the biotechnological production of proteins.
Participants will learn basic and applied protein aggregation concepts and explore experimental methods to study these processes computationally and in vitro. Trainees will work in groups and receive hands-on training in the re-design of protein solubility and the screening of small anti-aggregational molecules of therapeutic interest. The program will integrate practical sessions with talks by leading scientists and industries in the field.
1.1 Target audience and requirements
This course is intended for Bachelor, Master, PhD students, young researchers and technicians that have a basic understanding of protein aggregation.
1.2 Instructors and speakers
- Fabrizio Chiti (University of Florence, Italy)
- Enrique Claro (Autonomous University of Barcelona, Spain)
- Xavier Fernàndez-Busquets (Institute for Bioengineering of Catalonia and Barcelona Centre for International Health Research, Spain)
- Javier Garcia-Pardo (Autonomous University of Barcelona, Spain)
- Rafael Giraldo (Spanish National Centre for Biotechnology, Spain)
- Henrik Jensen (Fidabio)
- Ariadna Laguna (Vall d’Hebron Research Institute, Spain)
- Pedro Martins (University of Porto, Portugal)
- Susanna Navarro (Autonomous University of Barcelona, Spain)
- Daniel Otzen (University of Aarhus, Denmark)
- Irantzu Pallarès (Autonomous University of Barcelona, Spain)
- Carlos Pintado-Grima (Autonomous University of Barcelona, Spain)
- Jordi Pujols (Autonomous University of Barcelona, Spain)
- Nerea Roher (Autonomous University of Barcelona, Spain)
- Rosa Sebastián (Autonomous University of Barcelona, Spain)
- José María Valpuesta (National Center for Biotechnology, Spain)
- Salvador Ventura (Autonomous University of Barcelona, Spain)
- Rita Vilaça (University of Porto, Portugal)
1.3 Organizing committee
- Salvador Ventura (Autonomous University of Barcelona, Spain)
- Susanna Navarro (Autonomous University of Barcelona, Spain)
- Irantzu Pallarès (Autonomous University of Barcelona, Spain)
- Javier Garcia-Pardo (Autonomous University of Barcelona, Spain)
- Jordi Pujols (Autonomous University of Barcelona, Spain)
- Michał Burdukiewicz (Autonomous University of Barcelona, Spain and Medical University of Białystok, Poland)
- Carlos Pintado-Grima (Autonomous University of Barcelona, Spain)
- Oriol Bárcenas (Autonomous University of Barcelona, Spain)
- Lorena Muñoz (Autonomous University of Barcelona, Spain)
The content of this document was produced with the financial support of the European Union. It only represents the views of the authors and cannot be considered to reflect the views of the European Commission, which is free of any responsibility for the use of the information contained herein.
All materials are licensed under the CC-BY license unless noted otherwise.